The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective

被引:54
|
作者
Garbaccio, Robert M. [1 ]
Parmee, Emma R. [1 ]
机构
[1] Merck Res Labs, Global Chem, Mailstop 14-2,740 Sumneytown Pike, West Point, PA 19486 USA
来源
CELL CHEMICAL BIOLOGY | 2016年 / 23卷 / 01期
关键词
SMALL-MOLECULE INHIBITORS; PEPTIDASE-IV INHIBITOR; RECEPTOR; TARGET; ANTAGONIST; POTENT; CELLS; AKT; REPLICATION; MK-0657;
D O I
10.1016/j.chembiol.2015.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical probes represent an important component of both academic and pharmaceutical drug discovery research. As a complement to prior reviews that have defined this scientific field, we aim to provide an industry perspective on the value of having high-quality chemical probes throughout the course of preclinical research. By studying examples from the internal Merck pipeline, we recognize that these probes require significant collaborative investment to realize their potential impact in clarifying the tractability and translation of a given therapeutic target. This perspective concludes with recommendations for chemical probe discovery aimed toward maximizing their potential to identify targets that result in the successful delivery of novel therapeutics.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [41] PEGylated drug delivery systems in the pharmaceutical field: past, present and future perspective
    Armengol, Eva Sanchez
    Unterweger, Alexander
    Laffleur, Flavia
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 48 (04) : 129 - 139
  • [42] Lessons learned in TB drug discovery: an industrial chemist's perspective
    Jiricek, Jan
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (12) : 1377 - 1380
  • [43] Organ-on-chip applications in drug discovery: an end user perspective
    Clapp, Naomi
    Amour, Augustin
    Rowan, Wendy C.
    Candarlioglu, Pelin L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (04) : 1881 - 1890
  • [44] Ebola virus: A gap in drug design and discovery - experimental and computational perspective
    Balmith, Marissa
    Faya, Mbuso
    Soliman, Mahmoud E. S.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 89 (03) : 297 - 308
  • [46] Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
    Miljkovic, Filip
    Bajorath, Juergen
    MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 4849 - 4859
  • [47] Impact of Cross-Coupling Reactions in Drug Discovery and Development
    Buskes, Melissa J.
    Blanco, Maria-Jesus
    MOLECULES, 2020, 25 (15):
  • [48] Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening
    Yamaguchi, Kiyoshi
    Nagatoishi, Satoru
    Tsumoto, Kouhei
    Furukawa, Yoichi
    CANCER SCIENCE, 2020, 111 (03) : 783 - 794
  • [49] The increasing impact of Chinese innovative drug research on the global stage with a focus on drug discovery
    Luo, Wei
    Srinivasulu, Cherukupalli
    Hao, Xia
    Liu, Xinyong
    Zhan, Peng
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (10) : 1115 - 1120
  • [50] Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
    Villoutreix, Bruno O.
    Kuenemann, Melaine A.
    Poyet, Jean-Luc
    Bruzzoni-Giovanelli, Heriberto
    Labbe, Celine
    Lagorce, David
    Sperandio, Olivier
    Miteva, Maria A.
    MOLECULAR INFORMATICS, 2014, 33 (6-7) : 414 - 437